License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs Interferon Beta-1a in early active relapsing remitting Multiple Sclerosis

Does sequential treatment with Mitoxantrone and Glatiramer Acetate Copaxone vs Interferon Beta in early active relapsing remitting Multiple Sclerosis lead to better patient outcomes in terms of the reduced relapses reduced disability and improved quality of life

FieldValue
Modified
2019-12-23
Release Date
2019-05-11
Identifier
050b43e5-f7e9-409e-a250-ab776edc0072
License
License Not Specified
Public Access Level
Public